Poseida Sinks On Prostate Cancer CAR-T Clinical Hold

The Newly Public Company’s Stock Closed Down 30%

stopping the Dominio effect
A Phase I trial of P-PSMA-101 was stopped after a prostate cancer patient died

More from Clinical Trials

More from R&D